Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,041 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,668 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00422708 | Local Anesthesia for Prostate Biopsy | completed | Phase 4 | 243 | Mayo ClinicOTHER | 1 | Jan 20, 2010 | clinicaltrials |
| NCT00733109 | Management of Cervical Intraepithelial Neoplasia Grade 2(CIN2) | completed | Phase 4 | 90 | Universidade Cidade de Sao PauloOTHER | 1 | Jan 11, 2010 | clinicaltrials |
| NCT00280098 |
| Docetaxel in the Treatment of Hormone Refractory Prostate Cancer |
| completed |
| Phase 4 |
| 30 |
| SanofiINDUSTRY |
| 1 |
| Dec 7, 2009 |
| clinicaltrials |
| NCT00035997 | Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis | completed | Phase 4 | 261 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 23, 2009 | clinicaltrials |
| NCT00159328 | Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids | completed | Phase 4 | 50 | Imperial College LondonOTHER | 1 | Aug 13, 2008 | clinicaltrials |
| NCT00199485 | Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate Cancer | completed | Phase 4 | 44 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Jul 29, 2008 | clinicaltrials |
| NCT00590213 | Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX(COMART) | completed | Phase 4 | 125 | AstraZenecaINDUSTRY | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00190697 | A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment | completed | Phase 4 | 70 | Eli Lilly and CompanyINDUSTRY | 1 | May 25, 2007 | clinicaltrials |
| NCT00293696 | Casodex/Zoladex Biomarkers in Localised Prostate Cancer | completed | Phase 4 | 30 | Tampere UniversityOTHER | 1 | May 8, 2007 | clinicaltrials |
Data updated 23 days agoSource updated Jan 20, 2010source: clinicaltrials